发明授权
- 专利标题： Substituted annellated pyrimidines and use thereof
- 专利标题（中）： 取代的环状嘧啶及其用途
-
申请号： US13599975申请日： 2012-08-30
-
公开(公告)号： US08859569B2公开(公告)日： 2014-10-14
- 发明人: Markus Follmann , Johannes-Peter Stasch , Gorden Redlich , Nils Griebenow , Dieter Lang , Frank Wunder , Walter Hübsch , Niels Lindner , Alexandros Vakalopoulos , Adrian Tersteegen
- 申请人： Markus Follmann , Johannes-Peter Stasch , Gorden Redlich , Nils Griebenow , Dieter Lang , Frank Wunder , Walter Hübsch , Niels Lindner , Alexandros Vakalopoulos , Adrian Tersteegen
- 申请人地址： DE Berlin DE Monheim
- 专利权人： Bayer Pharma Aktiengesellschaft,Bayer Intellectual Property GmbH
- 当前专利权人： Bayer Pharma Aktiengesellschaft,Bayer Intellectual Property GmbH
- 当前专利权人地址： DE Berlin DE Monheim
- 代理商 Karen B. King
- 优先权： DE102011082041 20110902; DE102012200351 20120111
- 主分类号： A01N43/90
- IPC分类号： A01N43/90 ; A61K31/519 ; C07D487/00 ; A61K31/541 ; A61K31/5383 ; A61K31/5377 ; C07D498/08 ; C07D519/00 ; C07D471/04 ; A61K45/06 ; C07D487/04 ; C07D491/20
摘要：
The present application relates to novel substituted annellated pyrimidines, methods for production thereof, use thereof alone or in combinations for treating and/or preventing diseases and use thereof for the production of medicinal products for treating and/or preventing diseases, in particular for treating and/or preventing cardiovascular diseases.
公开/授权文献
- US20130338137A1 Substituted annellated pyrimidines and use thereof 公开/授权日：2013-12-19
信息查询
IPC分类:
